Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.
2.

Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.

Beconi MG, Reed JR, Teffera Y, Xia YQ, Kochansky CJ, Liu DQ, Xu S, Elmore CS, Ciccotto S, Hora DF, Stearns RA, Vincent SH.

Drug Metab Dispos. 2007 Apr;35(4):525-32. Epub 2007 Jan 12.

3.

Species differences in metabolism and pharmacokinetics of a sphingosine-1-phosphate receptor agonist in rats and dogs: formation of a unique glutathione adduct in the rat.

Anari MR, Creighton MD, Ngui JS, Tschirret-Guth RA, Teffera Y, Doss GA, Tang W, Yu NX, Ciccotto SL, Hobra DF Jr, Coleman JB, Vincent SH, Evans DC.

Drug Metab Dispos. 2006 Aug;34(8):1367-75. Epub 2006 May 12.

4.

Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3.

Wang S, Hartley DP, Ciccotto SL, Vincent SH, Franklin RB, Kim MS.

Drug Metab Dispos. 2003 Jun;31(6):773-5.

5.

Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.

Schilder RJ, Gallo JM, Millenson MM, Bookman MA, Weiner LM, Rogatko A, Rogers B, Padavic-Shallers K, Boente M, Rosenblum N, Adams AL, Ciccotto S, Ozols RF.

J Clin Oncol. 2001 Feb 15;19(4):1183-94.

PMID:
11181685
6.

Distribution of small magnetic particles in brain tumor-bearing rats.

Pulfer SK, Ciccotto SL, Gallo JM.

J Neurooncol. 1999 Jan;41(2):99-105.

PMID:
10222429

Supplemental Content

Loading ...
Support Center